The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
Aging isn't classified as a disease by regulators like the FDA, so longevity biotech companies often pivot to targeting specific age-related diseases (including metabolic health, of course!) to get funding and approvals (this is a thread, see below).
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
we wanted to find very diseases of being old diseases things that the FDA has regulatory paths for and endpoints that you can get drugs approved on